Honoring the past, embracing the present, you are the future – journal of thoracic oncology electricity year 6


By the early 1970s it was clear that lung cancer was the leading cause of cancer death worldwide and was likely to remain so for many decades. A group of international experts in many facets of the lung cancer problem recognized that it would take a concerted and organized international and multidisciplinary effort to combat this dreaded disease. Since the 1970s, the International Association for the Study of Lung Cancer (IASLC) has promoted research and education into all aspects of lung cancer and other thoracic malignancies and has encouraged worldwide cancer prevention efforts.

According to its mission 76 gas station jobs statement, the IASLC must “embrace the study of the etiology, epidemiology, prevention, diagnosis, treatment, and all other aspects of lung cancer and other thoracic malignancies; provide education and information about lung cancer and other thoracic malignancies to IASLC members, to the medical community at large, and to the public; and use all available means to eliminate lung cancer and other thoracic malignancies as a health threat for the individual patient 1 electricity unit in kwh and throughout the world.” In the past 10 years, that mission has been embraced by a growing number of members worldwide across multiple disciplines, encompassing and expanding a large portfolio of scientific and educational activities to create what is now the premier society in the field of thoracic oncology.

The IASLC World Conference on Lung Cancer (WCLC) is the preeminent meeting for thoracic cancers, reaching an ever-increasing number of individuals who are singularly focused on thoracic malignancies each year. Scientifically, the most relevant and practice-changing research has been consistently presented at the WCLC. At the most recent WCLC in Toronto, Canada, four practice-changing abstracts were presented with simultaneous publication gas up the jet in the New England Journal of Medicine.

In 1998, the IASLC established its Lung Cancer Staging Project, which is an effort to collect a significant international database of lung cancer cases and their anatomical classifications. The IASLC collected and published a large amount of data regarding the size of tumors, lymph node involvement, and metastatic status that was then presented to the Union for International Cancer Control and the American Joint Committee on Cancer for evaluation. Before the IASLC Lung Cancer Staging Project, data collected for staging of lung cancer came from a smaller group of patients, based almost exclusively in the United States. In 2016, in partnership with the Union for International Cancer Control and the American Joint Committee on Cancer, the IASLC launched the eighth edition of the International Staging of Thoracic Malignancies. The staging system was based on nearly 100,000 cases collected by multidisciplinary investigators from all the geographic areas of the world. The IASLC staging committee is currently working on the ninth edition electricity questions and answers physics, which will include the addition of molecular characteristics, to be released by 2024. We invite your participation in this next phase of the project.

The IASLC, together with the American Thoracic Society and the European Respiratory Society, collaborated to produce a new international multidisciplinary classification of lung adenocarcinoma, a subtype that accounts for almost half of all lung cancers. Published in early 2011, the new classification was the first revision to the lung adenocarcinoma classification since 2004 and the first to use a multidisciplinary approach to classify this type of cancer. It was incorporated into the WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, which gas 69 was published by the WHO in 2015.

The IASLC organizes several meetings in addition to the WCLC. We have added many regional (such as Latin America, Africa, Asia, and Europe in collaboration with local societies) and scientific meetings (targeted therapy, SCLC, neoadjuvant therapy) that are highly regarded for their educational offerings, geographic diversity, global collaboration, networking opportunities, and high-level scientific content, all of which have been crafted through a multidisciplinary lens.

As thought leaders in the field, IASLC members have authored two editions of the IASLC textbook, IASLC Thoracic Oncology; numerous atlases to guide in the treatment of targeted and immunotherapies; hundreds of leading scientific papers; and numerous declarations. IASLC members have and continue to greatly influence tobacco control policies around the world and have crafted pathology standards that have led to more effective treatment of thoracic malignancies.

Additionally, the gas and bloating IASLC Foundation has continuously invested in future generations of lung cancer researchers through fellowships and research grants, ranging from small travel grants to large multiyear research grants, many of which are awarded in collaboration with other philanthropic organizations dedicated to the field of thoracic cancers.

The IASLC also continues to champion patients, survivors, and patient advocates in our work, ensuring that their voices are included as part of our multidisciplinary approach. In addition, we are proud of the growth that Lung Cancer Awareness Month has had and are grateful to the vast network of partners who gas after eating red meat contribute to this important campaign.

In 2019, we will not only continue our core activities but will also create an important new initiative in early screening and detection and add another scientific meeting that will be focused solely on mesothelioma and held in July. We are also exploring exciting new collaborations to better affect the survival rate of patients with lung cancer worldwide, thus bringing more attention and resources to our shared cause.

Jack Welch, chairman and chief executive officer of General Electric from 1981 to 2001, once said, “Change before you have to.” Accordingly, the IASLC decided more than 2 years ago to reorganize itself according to a new strategic plan ( Fig. 1 Fig. 1) to set our course for the next decade and capture the dynamic nature of our organization. The strategic plan represents our roadmap for the future and details our areas of emphasis and priority. It indicates how the IASLC will not only maintain but also advance our leadership in the field and how we will explore new avenues of interest for our members. The strategic plan seeks to modernize our organization while honoring our history and to make investments necessary to create a nimble and responsive organization that can set the pace in an emerging and dynamic gas bubbles in colon field.

One of the main duties of a membership association is to provide value to its members through high-quality and relevant offerings and deeper, more efficient mechanisms for engagement. Creating a robust experience for IASLC members and honoring our commitment to geographic and electricity calculator discipline diversity is our goal. In 2019, we are reorganizing ourselves and investing in the appropriate technologies to meet that goal. These investments, which will take the form of additional human resources talent and corresponding operational systems, will make us better. We will also optimize our approach to committee engagement so that your experience will be even more meaningful.

Additionally, we intuitively know that to conquer thoracic cancers worldwide, we cannot do it alone. Creating strategic partnerships to establish more fruitful collaborations with other national and international scientific societies that enable each of us to go deeper and to amplify our collective and individual efforts is essential. To do that, we will engage and attract the interest of other relevant societies and define common paths of collaboration.

The most challenging part for any scientific society is to understand the differences in generational and geographic needs. We need to identify the best new talent—the rising stars in our field—who will not only disrupt conventional thinking but also lead the IASLC in the future. Specific actions will be considered, and others are already in place, to convince younger generations to see themselves in the IASLC’s mission. Additionally, the IASLC will continue gas variables pogil answers to identify appropriate opportunities that focus on primary prevention of lung cancer in underrepresented areas; disparities in access to new drugs; and new treatment options depending on the geographic, financial, and/or social environments.

The IASLC has a clear and compelling mission. Our community of members and supporters is vast, and we have a strong financial position from which we can make the necessary investments in our organization. The IASLC’s story has been alive for nearly 45 years, and we stand on the shoulders of those visionaries who conceived of and built our organization. The IASLC will continue its leadership in supporting today’s and tomorrow’s lung cancer researchers and practitioners, as well as its gas and electric credit union vital role communicating information and new developments in thoracic oncology. The IASLC’s organizational vision of conquering lung and other thoracic cancers looks ahead to the future of lung cancer medicine and to continuing the global progress in lung cancer through research, education, prevention, and treatment in a multidisciplinary manner. Our commitment to you is that we will honor the past by seizing the opportunity that the present holds and further strengthen our organization so that together we will conquer thoracic cancers worldwide.